Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Biopharmaceutical Contract Manufacturing(BCMO) Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Status and Forecast (2016-2027)
      • 1.3.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Biopharmaceutical Contract Manufacturing(BCMO) Supply by Company

    • 2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Sales Value by Company
    • 2.2 Biopharmaceutical Contract Manufacturing(BCMO) Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Biopharmaceutical Contract Manufacturing(BCMO) Market Status by Category

    • 3.1 Biopharmaceutical Contract Manufacturing(BCMO) Category Introduction
      • 3.1.1 Mammalian Based Manufacturing
      • 3.1.2 Microbial Based Manufacturing
      • 3.1.3 Other
    • 3.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Biopharmaceutical Contract Manufacturing(BCMO) Market Status by End User/Segment

    • 4.1 Biopharmaceutical Contract Manufacturing(BCMO) Segment by End User/Segment
      • 4.1.1 Bio-Pharmaceutical Companies
      • 4.1.2 Pharmaceutical Companies
      • 4.1.3 Drug Discovery Companies
      • 4.1.4 Other
    • 4.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Status by Region

    • 5.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market by Region
    • 5.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Status
    • 5.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Status
    • 5.4 Asia Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Status
    • 5.5 Central & South America Biopharmaceutical Contract Manufacturing(BCMO) Market Status
    • 5.6 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Status

    6 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Status

    • 6.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Status

    • 7.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Status

    • 8.1 Asia Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Biopharmaceutical Contract Manufacturing(BCMO) Market Status

    • 9.1 Central & South America Biopharmaceutical Contract Manufacturing(BCMO) Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Status

    • 10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast by Category and by End User/Segment

    • 12.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Sales Value Forecast (2022-2027)
    • 12.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecast by Category
    • 12.3 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecast by End User/Segment

    13 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast by Region/Country

    • 13.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Sandoz
      • 14.1.1 Company Information
      • 14.1.2 Biopharmaceutical Contract Manufacturing(BCMO) Product Introduction
      • 14.1.3 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Rentschler Biotechnologie
      • 14.2.1 Company Information
      • 14.2.2 Biopharmaceutical Contract Manufacturing(BCMO) Product Introduction
      • 14.2.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 ProBioGen AG
      • 14.3.1 Company Information
      • 14.3.2 Biopharmaceutical Contract Manufacturing(BCMO) Product Introduction
      • 14.3.3 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Lonza Group Ltd
      • 14.4.1 Company Information
      • 14.4.2 Biopharmaceutical Contract Manufacturing(BCMO) Product Introduction
      • 14.4.3 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Fujifilm Diosynth Biotechnology
      • 14.5.1 Company Information
      • 14.5.2 Biopharmaceutical Contract Manufacturing(BCMO) Product Introduction
      • 14.5.3 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Celonic GmbH
      • 14.6.1 Company Information
      • 14.6.2 Biopharmaceutical Contract Manufacturing(BCMO) Product Introduction
      • 14.6.3 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Boehringher Ingelheim
      • 14.7.1 Company Information
      • 14.7.2 Biopharmaceutical Contract Manufacturing(BCMO) Product Introduction
      • 14.7.3 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 BIOMEVA GmbH
      • 14.8.1 Company Information
      • 14.8.2 Biopharmaceutical Contract Manufacturing(BCMO) Product Introduction
      • 14.8.3 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Biopharmaceutical Contract Manufacturing(BCMO) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Biopharmaceutical Contract Manufacturing(BCMO) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Mammalian Based Manufacturing
      Microbial Based Manufacturing
      Other

      Segmented by End User/Segment
      Bio-Pharmaceutical Companies
      Pharmaceutical Companies
      Drug Discovery Companies
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Sandoz
      Rentschler Biotechnologie
      ProBioGen AG
      Lonza Group Ltd
      Fujifilm Diosynth Biotechnology
      Celonic GmbH
      Boehringher Ingelheim
      BIOMEVA GmbH
      Buy now